3 completed, 1 active not recruiting. 2 Phase 2, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Merz Aesthetics GmbH: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU) NT 201, NT 201 Placebo - Neuromuscular Agents, Peripheral Nervous System Agents | Phase 3 | Active not recruiting | Merz Aesthetics GmbH | 300 | 2025-10-01 | 2026-09-10 |
| A Study of NT 201 Doses in the Treatment of Platysma Prominence NT 201, NT 201 Placebo - Platysma Prominence | Phase 2 | Completed | Merz Aesthetics GmbH | 73 | 2023-03-22 | 2024-10-21 |
| Investigation of the Effectiveness and Safety of MRZF111 in the Treatment of Décolleté Wrinkles MRZF111 - Décolleté Wrinkles | Not applicable | Completed | Merz Aesthetics GmbH | 117 | 2019-12-04 | 2023-12-26 |
| Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines NT 201 - Moderate to Severe Glabellar Frown Lines | Phase 2 | Completed | Merz Aesthetics GmbH | 241 | 2019-01-23 | 2023-11-15 |
incobotulinumtoxinA (3) · Botulinum Toxins, Type A (1)
Germany (3) · United States (2) · France (1) · Poland (1) · Spain (1)
2018 (1)